AI空间生物标志物分析公司Nucleai获巨额投资助力科研发展
近日，AI空间生物标志物分析领域的初创公司Nucleai宣布成功获得1400万美元的B+轮融资。此次融资由M Ventures领投，众多知名投资机构如Section 32、Sanofi Ventures、Debiopharm、复星锐正资本、Vertex Ventures Israel和Grove Ventures等纷纷参与投资。
Nucleai公司专注于利用人工智能和机器学习技术，在细胞和组织层面分析病理图像和空间数据，以预测治疗结果。其独特的分析能力使其成为生物医药领域的领军者，此次融资无疑为其进一步发展注入了强大的动力。
据悉，Nucleai将利用此次融资推动研发创新，加速其在AI空间生物标志物分析领域的布局。未来，该公司有望通过深度学习和大数据分析技术，为医药研发提供更精确、高效的解决方案，推动生物医药产业的快速发展。
业内专家表示，此次融资将为Nucleai带来更大的发展空间，有望引领AI在生物医药领域的应用进入新的发展阶段。
英语如下：
News Title: “Nucleai Raises $14 Million in B+ Round Funding, AI-Powered Biomarker Analysis Ushers in a New Medical Revolution”
Keywords: Nucleai startup, successful funding, AI biomarker analysis
News Content:
AI Spatial Biomarker Analysis Company Nucleai Gets Major Investment to Boost Scientific Development
Recently, Nucleai, a startup in the field of AI spatial biomarker analysis, announced a successful B+ round funding of $14 million. Led by M Ventures, this round of funding also saw participation from prominent investment institutions such as Section 32, Sanofi Ventures, Debiopharm, Fosun锐正Capital, Vertex Ventures Israel, and Grove Ventures.
Nucleai specializes in utilizing artificial intelligence and machine learning technologies to analyze pathological images and spatial data at the cellular and tissue levels to predict treatment outcomes. Its unique analytical capabilities have made it a leader in the field of biomedicine, and this funding injection is undoubtedly a strong driving force for its further development.
It is reported that Nucleai will use this funding to drive research and development innovation and accelerate its布局 in the field of AI spatial biomarker analysis. In the future, the company is expected to provide more precise and efficient solutions for pharmaceutical research and development through deep learning and big data analytics technologies, driving the rapid development of the biomedicine industry.
Industry experts indicate that this funding will provide Nucleai with greater room for development and is expected to lead the application of AI in the biomedicine field into a new stage of development.
【来源】https://ai-bot.cn/go/?url=aHR0cHM6Ly93d3cuY2FsY2FsaXN0ZWNoLmNvbS9jdGVjaG5ld3MvYXJ0aWNsZS9yMTFicmFjMWE%3D
Views: 1